ProfileGDS5822 / ILMN_1236022
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 38% 20% 53% 33% 8% 25% 35% 19% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 117.538
GSM1276600PDAC Late Ablation Control 214.820
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 12153
GSM1276603PDAC Late Ablation 216.133
GSM1276604PDAC Late Ablation 37.48
GSM1303940PDAC Late Ablation_anti-CTLA4 114.225
GSM1303941PDAC Late Ablation_anti-CTLA4 21735
GSM1303942PDAC Late Ablation_anti-CTLA4 310.119